drugset / Trial / NCT00509834
A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Proven Candidaemia
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a phase-I, double-blind, randomized study with hLF1-11 to study the tolerability and early efficacy of hLF1-11 compared to standard fluconazole therapy in hospitalized patients with invasive Candida infection.
Timeline
- Start
- 2008-07
- Primary completion
- 2009-01
- Completion
- 2009-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | hLF1-11 | Peptide | 0.5 mg | Intravenous |
| Background | Fluconazole | Small molecule | 1 g | Intravenous |